Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

Gastroenterology

Volumn 153, Issue 2, 2017, Pages 420-429

  Hooi, James K Y ^a   Lai, Wan Ying ^a   Ng, Wee Khoon ^a,b   Suen, Michael M Y ^a   Underwood, Fox E ^c   Tanyingoh, Divine ^c   Malfertheiner, Peter ^d   Graham, David Y ^e   Wong, Vincent W S ^a   Wu, Justin C Y ^a   Chan, Francis K L ^a   Sung, Joseph J Y ^a   Kaplan, Gilaad G ^c   Ng, Siew C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c UNIVERSITY OF CALGARY   (Canada)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bacteria; Europe; Incidence; Stomach

Indexed keywords

AFRICA; ALBANIA; ARGENTINA; ARTICLE; AUSTRALIA; BAHAMAS; BELGIUM; BENIN; BRAZIL; BURKINA FASO; CANADA; CARIBBEAN; CHILE; CHINA; CONGO; CROATIA; CZECH REPUBLIC; DENMARK; EASTERN EUROPE; ECUADOR; EGYPT; ESTONIA; EUROPE; FINLAND; FRANCE; GERMANY; GREECE; GREENLAND; GUADELOUPE; HELICOBACTER INFECTION; HUMAN; ICELAND; INDIA; IRAN; IRELAND; ISRAEL; ITALY; JAPAN; KAZAKHSTAN; KOREA; LATVIA; LEBANON; LIBYAN ARAB JAMAHIRIYA; MALAYSIA; META ANALYSIS; MEXICO; NEPAL; NETHERLANDS; NEW ZEALAND; NIGERIA; NORWAY; OMAN; PACIFIC ISLANDS; PAKISTAN; PANAMA; POLAND; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; ROMANIA; RUSSIAN FEDERATION; SAN MARINO; SAUDI ARABIA; SINGAPORE; SOUTH AFRICA; SPAIN; SWEDEN; SWITZERLAND; TAIWAN; THAILAND; TUNISIA; TURKEY (REPUBLIC); UNITED KINGDOM; UNITED STATES; VIET NAM; WESTERN EUROPE; ASIA; GLOBAL HEALTH; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; STATISTICS AND NUMERICAL DATA; WESTERN HEMISPHERE;

AFRICA; AMERICAS; ASIA; EUROPE; GLOBAL HEALTH; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OCEANIA; PREVALENCE;

EID: 85021862389     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.04.022     Document Type: Article

References (37)

1. Marshall, B.J., Warren, J.R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:8390 (1984), 1311–1315.
2. Malfertheiner, P., Megraud, F., O'Morain, C., et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56 (2007), 772–781.
3. Liou, J.M., Fang, Y.J., Chen, C.C., et al. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 388:10058 (2016), 2355–2365.
4. Graham, D.Y., History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol 20 (2014), 5191–5204.
5. Nagy, P., Johansson, S., Molloy-Bland, M., Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathog, 8, 2016, 8.
6. Wang, C., Yuan, Y., Hunt, R.H., The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 102 (2007), 1789–1798.
7. Yokota, S., Konno, M., Fujiwara, S., et al. Intrafamilial, preferentially mother-to-child and intraspousal, Helicobacter pylori infection in japan determined by mutilocus sequence typing and random amplified polymorphic DNA fingerprinting. Helicobacter 20 (2015), 334–342.
8. Moher, D., Liberati, A., Tetzlaff, J., et al., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
9. Composition of macro Geographical (Continental) Regions, Geographical Sub-Regions, and Selected Economic and Other Groupings. Available at: http://unstats.un.org/unsd/methods/m49/m49regin.htm. Published September 26, 2016. Accessed November 18, 2016.
10. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Published 2014. Accessed November 18, 2016.
11. Molodecky, N.A., Soon, I.S., Rabi, D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54 e42 quiz e30.
12. QGIS Development Team. QGIS Geographic Information System. Open Source Geospatial Foundation Project. Available at: http://www.qgis.org/. Published 2016. Accessed January 21, 2017.
13. Duivenvoorde R. HTML Image Map Plugin for QGIS. Open Source Geospatial Foundation Project. http://hub.qgis.org/projects/imagemapplugin. Published 2014. Accessed January 21, 2017.
14. Natural Earth Development Team. Cultural Vectors. North American Cartographic Information Society. http://www.naturalearthdata.com. Published 2016. Accessed January 21, 2017.
15. Everhart, J.E., Kruszon-Moran, D., Perez-Perez, G.I., et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 181 (2000), 1359–1363.
16. Cardenas, V.M., Mulla, Z.D., Ortiz, M., et al. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 163 (2006), 127–134.
17. Parkinson, A.J., Gold, B.D., Bulkow, L., et al. High prevalence of Helicobacter pylori in the Alaska Native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol 7 (2000), 885–888.
18. Eslick, G.D., Lim, L.L., Byles, J.E., et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94 (1999), 2373–2379.
19. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49 (2001), 347–353.
20. Huang, J.Q., Sridhar, S., Chen, Y., et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114 (1998), 1169–1179.
21. Parsonnet, J., Friedman, G.D., Vandersteen, D.P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325 (1991), 1127–1131.
22. Uemura, N., Okamoto, S., Yamamoto, S., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001), 784–789.
23. International Agency for Research on Cancer Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. (IARC Working Group Reports, No. 8). 2014, International Agency for Research on Cancer, Lyon, France Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php Accessed November 18, 2016.
24. Kosunen, T.U., Pukkala, E., Sarna, S., et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: a cohort study. Int J Cancer 128 (2011), 433–439.
25. Takenaka, R., Okada, H., Kato, J., et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 25 (2007), 805–812.
26. Yeh, J.M., Kuntz, K.M., Ezzati, M., et al. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer 124 (2009), 157–166.
27. Lu, B., Li, M., Helicobacter pylori eradication for preventing gastric cancer. World J Gastroenterol 20 (2014), 5660–5665.
28. Zeng, M., Mao, X.H., Li, J.X., et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386:10002 (2015), 1457–1464.
29. Rupnow, M.F., Chang, A.H., Shachter, R.D., et al. Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. J Infect Dis 200 (2009), 1311–1317.
30. Correa, P., Piazuelo, M.B., Helicobacter pylori infection and gastric adenocarcinoma. US Gastroenterol Hepatol Rev 7 (2011), 59–64.
31. Kodaman, N., Pazos, A., Schneider, B.G., et al. Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci U S A 111 (2014), 1455–1460.
32. Graham, D.Y., Lu, H., Yamaoka, Y., African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis 10 (2009), 77–84.
33. Population Distribution and Basic Demographic Characteristic Report 2010. https://www.dosm.gov.my/v1/index.php?r=column/ctheme&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09&bul_id=MDMxdHZjWTk1SjFzTzNkRXYzcVZjdz09. Accessed November 18, 2016.
34. Goh, K.L., Parasakthi, N., The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur J Gastroenterol Hepatol 13 (2001), 177–183.
35. Kang, J.Y., Yeoh, K.G., Ho, K.Y., et al. Racial differences in Helicobacter pylori seroprevalence in Singapore: correlation with differences in peptic ulcer frequency. J Gastroenterol Hepatol 12:9−10 (1997), 655–659.
36. AbM, Azizah, Nor Saleh, I.T., Noor Hashima, A., et al. Malaysian National Cancer Registry Report 2007−2011. Malaysia Cancer Statistics, Data and Figure. 2016, National Cancer Institute, Ministry of Health, Putrajaya, Malaysia.
37. Windsor, H.M., Abioye-Kuteyi, E.A., Leber, J.M., et al. Prevalence of Helicobacter pylori in Indigenous Western Australians: comparison between urban and remote rural populations. Med J Aust 182 (2005), 210–213.